Myricx Bio

Developer of antibody drug conjugates for the treatment of cancer

placeLondon, England, United Kingdom calendar_todayFounded 2019 groups6 employees language myricxbio.com

Registered entities

Social engagement

Social engagement: 6.8K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include Sofinnova Partners, Brandon Capital, British Patient Capital, Novo Holdings.

Investor typeCountShare
Venture capital533%
Other / undisclosed1067%

Recent activity

17 Sep 2025
Leadership hire
VP, Regulatory Affairs
Coming soon